February 26, 2021 3:09 pm
Published by Fluidda
Prevention is the key to healthy lungs.The quality of life for patients with chronic lung diseases like asthma, COPD, and lung cancer can- and should be improved. The Dutch consortium... View Article
February 23, 2021 10:55 am
Published by Fluidda
In a recent study by Usmani et al. , FRI was used to evaluate lung deposition of extrafine beclomethasone dipropionate (BDP)/formoterol fumarate (FF)/glycopyrronium bromide (GB) and extrafine BDP/FF delivered through pressurized metered... View Article
January 28, 2021 1:38 pm
Published by Fluidda
FRI is able to differentiate moderate to severe versus limited disease and to detect disease progression in systemic sclerosis. Systemic sclerosis–associated ILD accounts for up to 20% of mortality in these patients... View Article
January 20, 2021 2:39 pm
Published by Fluidda
FRI on PBS news hour: Medical community scrambles to understand COVID-19 ‘long haulers’ During a news item on PBS news hour, January 13, COVID-19 “long haulers” were discussed. Long haulers are COVID-19 patients... View Article
January 8, 2021 3:44 pm
Published by Fluidda
Today, one year into the COVID-19 pandemic, we live in a changed world. With over a million deaths and many millions suffering long-term disability as a result of lasting damage... View Article
December 4, 2020 11:13 am
Published by Fluidda
Galapagos Announces Positive Topline Results in Phase 2 Study Using FRI Imaging Parameters While Investigating New Medication for IPF Patients. The PINTA trial was a randomized, double-blind, placebo-controlled trial investigating... View Article
November 27, 2020 11:26 am
Published by Fluidda
Evaluations of inhaler use have demonstrated that mishandling of pMDIs (Pressurized Meter Dose Inhalers) is commonplace. One of the most common errors is the failure to coordinate inhalation with actuation... View Article
November 23, 2020 11:53 am
Published by Fluidda
The added value of FRI in treating lung diseases. Fluidda developed a large number of HRCT-derived imaging parameters, based on its proprietary Functional Respiratory Imaging (FRI) technique, to generate very... View Article
November 18, 2020 9:31 am
Published by Fluidda
The use of Fluidda’s FRI technology in the combat against COPD. The exact prevalence of COPD worldwide is largely unknown, but estimates have varied from 7-19%. The Burden of Obstructive Lung Disease (BOLD) study... View Article
November 6, 2020 2:50 pm
Published by Fluidda
Delta Hospital uses new imaging technology for better triage and optimal treatment of COVID-19 patients. Due to the very large number of Corona patients who now report daily for hospitalization,... View Article